325 related articles for article (PubMed ID: 2881524)
1. Beta-adrenergic blocking agents in the treatment of hypertension. Choices based on pharmacological properties and patient characteristics.
Wallin JD; Shah SV
Arch Intern Med; 1987 Apr; 147(4):654-9. PubMed ID: 2881524
[TBL] [Abstract][Full Text] [Related]
2. Beta-blockers in hypertension.
Hansson L
J Hypertens Suppl; 1987 Aug; 5(3):S61-7. PubMed ID: 2889813
[TBL] [Abstract][Full Text] [Related]
3. Do we need a new classification of beta-blockers?
Kendall MJ
J Hum Hypertens; 1990 Jun; 4 Suppl 2():27-9. PubMed ID: 1973460
[TBL] [Abstract][Full Text] [Related]
4. Beta blockers: the extended family.
Hager WD; Messineo FC; Katz AM
Adv Intern Med; 1984; 30():201-29. PubMed ID: 6152107
[TBL] [Abstract][Full Text] [Related]
5. Beta blockers in hypertension: a review.
Kelly KL
Am J Hosp Pharm; 1976 Dec; 33(12):1284-90. PubMed ID: 11687
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
Lemmer B
Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
[TBL] [Abstract][Full Text] [Related]
7. Managing the elderly patient with both hypertension and pulmonary disease.
Krane NK; Wallin JD
Geriatrics; 1987 Apr; 42(4):45-9, 52. PubMed ID: 2881848
[TBL] [Abstract][Full Text] [Related]
8. The role of the new beta-blockers in treating cardiovascular disease.
Weber MA
Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
[TBL] [Abstract][Full Text] [Related]
9. [Clinical application of beta-blockers with particular reference to hypertension].
Kocijancić M
Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():10-6. PubMed ID: 18193806
[TBL] [Abstract][Full Text] [Related]
10. Mode of action of beta-adrenergic blocking drugs in hypertension.
Prichard BN; Owens CW
Clin Physiol Biochem; 1990; 8 Suppl 2():1-10. PubMed ID: 1982756
[TBL] [Abstract][Full Text] [Related]
11. Comparison of beta-blockade and ACE inhibitors in the treatment of hypertension.
Prichard BN; Saul PA
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S81-5. PubMed ID: 11527141
[TBL] [Abstract][Full Text] [Related]
12. Are tolerability concerns a class effect of beta-blockers in treating patients with hypertension?
Kountz DS
Postgrad Med; 2009 Jan; 121(1):14-24. PubMed ID: 19179810
[TBL] [Abstract][Full Text] [Related]
13. The significance of beta1-beta2-selectivity and intrinsic sympathomimetic activity in beta-blockers, with particular reference to antihypertensive treatment.
Imhof P
Adv Clin Pharmacol; 1976; 11():26-32. PubMed ID: 25568
[TBL] [Abstract][Full Text] [Related]
14. Beta-blockers and hypertension: carbon copies or a real choice.
Whipps RG; Fisher ML; Plotnick GD
Compr Ther; 1984 Sep; 10(9):12-8. PubMed ID: 6149036
[TBL] [Abstract][Full Text] [Related]
15. [Clinical aspects of use of beta-blockers in the treatment of arterial hypertension].
Widimský J
Vnitr Lek; 1997 Apr; 43(4):221-5. PubMed ID: 9601840
[TBL] [Abstract][Full Text] [Related]
16. Differences in betablocking drugs in cardiovascular therapy.
Iisalo E; Heikkilä J
Ann Clin Res; 1988; 20(5):324-33. PubMed ID: 2905877
[TBL] [Abstract][Full Text] [Related]
17. The role of beta-blockers as a cornerstone of cardiovascular therapy.
Hollenberg NK
Am J Hypertens; 2005 Dec; 18(12 Pt 2):165S-168S. PubMed ID: 16373194
[TBL] [Abstract][Full Text] [Related]
18. Beta-blockers, dyslipidemia, and coronary artery disease. A reassessment.
Burris JF
Arch Intern Med; 1993 Sep; 153(18):2085-92. PubMed ID: 8104394
[TBL] [Abstract][Full Text] [Related]
19. [Beta blockers in the treatment of arterial hypertension].
Spinar J; Vítovec J
Cas Lek Cesk; 1998 May; 137(9):278-81. PubMed ID: 9650357
[TBL] [Abstract][Full Text] [Related]
20. Evolving mechanisms of action of beta blockers: focus on nebivolol.
Mason RP; Giles TD; Sowers JR
J Cardiovasc Pharmacol; 2009 Aug; 54(2):123-8. PubMed ID: 19528811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
